A checklist for designing and reporting cancer drug phase 3 clinical trials – ecancer
Dr Bishal Gyawali talks to ecancer about a checklist for reporting of phase 3 randomised controlled trials of cancer drugs. The checklist, developed by Commo
Related Articles
The 5th Annual OncoAlert Colloquium
The Year in Review in Oncology 2024 brought to you by some of the Worlds TOP experts!
Hematology & Medical Oncology Practice Updates and Board Review 2025 | Mayo Clinic School of Continuous Professional Development | CME Course Conference
February 3 – 7, 2025 – The Ritz Carlton Maui – Kapalua, Hawaii This course offers Live (in-person) and Livestream (virtual) attendance options. The Mayo…
The 5th Annual OncoAlert Colloquium
The Year in Review in Oncology 2024 brought to you by some of the Worlds TOP experts!
The 5th Annual OncoAlert Colloquium
The Year in Review in Oncology 2024 brought to you by some of the Worlds TOP experts!
U.S. taxpayers should stop funding clinical trials of industry-owned drugs
Federally funded cancer research, particularly clinical trials research, needs course correction.
The 5th Annual OncoAlert Colloquium
The Year in Review in Oncology 2024 brought to you by some of the Worlds TOP experts!
Lung cancer diagnoses on the rise among never-smokers worldwide
Research shows need for further studies into air pollution and other causal factors, expert says
The 5th Annual OncoAlert Colloquium
The Year in Review in Oncology 2024 brought to you by some of the Worlds TOP experts!
The 5th Annual OncoAlert Colloquium
The Year in Review in Oncology 2024 brought to you by some of the Worlds TOP experts!
Welcome! You are invited to join a webinar: IACH Webinar- Thalassemia: an update from ASH 2024. After registering, you will receive a confirmation email about joining the webinar.
Speaker: Farrukh Shah Dr Shah worked as a Consultant Haematologist at the Whittington Hospital NHS from 2004 to 2021 when she was appointed as Medical…
